The article "Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer" by Y. -X. Shi, B. -L. Ye, B. -R. Hu, X. -J. Ruan, published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10. 26355/eurrev₂01809₁5813-PMID: 30229824, has been retracted in accordance with the Publisher and the Editor in Chief. Following a previously published Expression of Concern, the Editor-in-Chief and the Publisher have completed an investigation into the issues raised in relation to this article. The investigation confirmed concerns regarding non-verifiable nucleotide sequence reagents and the use of inadequately authenticated cell lines, which undermine the reliability of the findings reported. The authors did not respond to correspondence regarding these concerns. The Editor-in-Chief and the Publisher have therefore decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
Shi et al. (2026) studied this question.